nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—colon cancer	0.647	1	CbGaD
Aminosalicylic Acid—MPO—superior mesenteric artery—colon cancer	0.0588	0.417	CbGeAlD
Aminosalicylic Acid—MPO—endothelium—colon cancer	0.00531	0.0376	CbGeAlD
Aminosalicylic Acid—Malabsorption—Methotrexate—colon cancer	0.00507	0.0642	CcSEcCtD
Aminosalicylic Acid—CHUK—epithelium—colon cancer	0.005	0.0355	CbGeAlD
Aminosalicylic Acid—MPO—blood vessel—colon cancer	0.0049	0.0347	CbGeAlD
Aminosalicylic Acid—CHUK—renal system—colon cancer	0.00464	0.0329	CbGeAlD
Aminosalicylic Acid—CHUK—lymphoid tissue—colon cancer	0.00385	0.0273	CbGeAlD
Aminosalicylic Acid—CHUK—digestive system—colon cancer	0.0038	0.027	CbGeAlD
Aminosalicylic Acid—Pericarditis—Fluorouracil—colon cancer	0.00327	0.0414	CcSEcCtD
Aminosalicylic Acid—CHUK—liver—colon cancer	0.00283	0.0201	CbGeAlD
Aminosalicylic Acid—ALOX5—smooth muscle tissue—colon cancer	0.00271	0.0192	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—colon cancer	0.00252	0.0179	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—colon cancer	0.00241	0.0171	CbGeAlD
Aminosalicylic Acid—MPO—epithelium—colon cancer	0.00238	0.0169	CbGeAlD
Aminosalicylic Acid—PTGS1—blood vessel—colon cancer	0.00232	0.0165	CbGeAlD
Aminosalicylic Acid—Taste metallic—Methotrexate—colon cancer	0.00231	0.0293	CcSEcCtD
Aminosalicylic Acid—PTGS2—blood vessel—colon cancer	0.00222	0.0157	CbGeAlD
Aminosalicylic Acid—MPO—renal system—colon cancer	0.00221	0.0157	CbGeAlD
Aminosalicylic Acid—Encephalopathy—Fluorouracil—colon cancer	0.0022	0.0279	CcSEcCtD
Aminosalicylic Acid—CHUK—lymph node—colon cancer	0.00217	0.0154	CbGeAlD
Aminosalicylic Acid—ALOX5—lymphoid tissue—colon cancer	0.00217	0.0154	CbGeAlD
Aminosalicylic Acid—ALOX5—digestive system—colon cancer	0.00214	0.0152	CbGeAlD
Aminosalicylic Acid—Lymphoma—Methotrexate—colon cancer	0.00211	0.0267	CcSEcCtD
Aminosalicylic Acid—PTGS2—gall bladder—colon cancer	0.00209	0.0148	CbGeAlD
Aminosalicylic Acid—Mesalazine—PPARG—colon cancer	0.00207	0.398	CrCbGaD
Aminosalicylic Acid—ALOX5—bone marrow—colon cancer	0.00198	0.014	CbGeAlD
Aminosalicylic Acid—MPO—lymphoid tissue—colon cancer	0.00184	0.013	CbGeAlD
Aminosalicylic Acid—MPO—digestive system—colon cancer	0.00181	0.0129	CbGeAlD
Aminosalicylic Acid—Pericarditis—Methotrexate—colon cancer	0.0017	0.0215	CcSEcCtD
Aminosalicylic Acid—MPO—bone marrow—colon cancer	0.00167	0.0119	CbGeAlD
Aminosalicylic Acid—ALOX5—liver—colon cancer	0.0016	0.0113	CbGeAlD
Aminosalicylic Acid—Hypothyroidism—Capecitabine—colon cancer	0.00154	0.0195	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Capecitabine—colon cancer	0.00154	0.0195	CcSEcCtD
Aminosalicylic Acid—MPO—liver—colon cancer	0.00135	0.00958	CbGeAlD
Aminosalicylic Acid—PTGS2—embryo—colon cancer	0.00132	0.00939	CbGeAlD
Aminosalicylic Acid—ALOX5—lymph node—colon cancer	0.00122	0.00868	CbGeAlD
Aminosalicylic Acid—Eruption—Methotrexate—colon cancer	0.0012	0.0151	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Methotrexate—colon cancer	0.00115	0.0145	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Irinotecan—colon cancer	0.00114	0.0144	CcSEcCtD
Aminosalicylic Acid—PTGS1—epithelium—colon cancer	0.00113	0.00802	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS2—colon cancer	0.00112	0.214	CrCbGaD
Aminosalicylic Acid—PTGS1—smooth muscle tissue—colon cancer	0.00109	0.00772	CbGeAlD
Aminosalicylic Acid—PTGS2—epithelium—colon cancer	0.00108	0.00766	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00107	0.0136	CcSEcCtD
Aminosalicylic Acid—PTGS1—renal system—colon cancer	0.00105	0.00744	CbGeAlD
Aminosalicylic Acid—PTGS2—smooth muscle tissue—colon cancer	0.00104	0.00738	CbGeAlD
Aminosalicylic Acid—MPO—lymph node—colon cancer	0.00104	0.00734	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00103	0.013	CcSEcCtD
Aminosalicylic Acid—PTGS2—renal system—colon cancer	0.001	0.00711	CbGeAlD
Aminosalicylic Acid—Abdominal distension—Irinotecan—colon cancer	0.000933	0.0118	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—colon cancer	0.000876	0.168	CrCbGaD
Aminosalicylic Acid—Weight decreased—Vincristine—colon cancer	0.000861	0.0109	CcSEcCtD
Aminosalicylic Acid—PTGS1—digestive system—colon cancer	0.00086	0.0061	CbGeAlD
Aminosalicylic Acid—Weight decreased—Irinotecan—colon cancer	0.000838	0.0106	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymphoid tissue—colon cancer	0.000832	0.0059	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Vincristine—colon cancer	0.000832	0.0105	CcSEcCtD
Aminosalicylic Acid—PTGS2—digestive system—colon cancer	0.000822	0.00583	CbGeAlD
Aminosalicylic Acid—Jaundice—Irinotecan—colon cancer	0.000805	0.0102	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Capecitabine—colon cancer	0.000802	0.0102	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Capecitabine—colon cancer	0.000795	0.0101	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Fluorouracil—colon cancer	0.000776	0.00982	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Capecitabine—colon cancer	0.00076	0.00962	CcSEcCtD
Aminosalicylic Acid—PTGS1—vagina—colon cancer	0.000759	0.00539	CbGeAlD
Aminosalicylic Acid—PTGS2—bone marrow—colon cancer	0.000758	0.00537	CbGeAlD
Aminosalicylic Acid—Vasculitis—Methotrexate—colon cancer	0.000754	0.00954	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Vincristine—colon cancer	0.000752	0.00952	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Vincristine—colon cancer	0.000747	0.00945	CcSEcCtD
Aminosalicylic Acid—Purpura—Capecitabine—colon cancer	0.000744	0.00942	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Fluorouracil—colon cancer	0.000738	0.00935	CcSEcCtD
Aminosalicylic Acid—PTGS2—vagina—colon cancer	0.000726	0.00515	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000718	0.00908	CcSEcCtD
Aminosalicylic Acid—Flatulence—Irinotecan—colon cancer	0.000636	0.00805	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Capecitabine—colon cancer	0.000624	0.0079	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—colon cancer	0.000621	0.119	CrCbGaD
Aminosalicylic Acid—Anaemia—Vincristine—colon cancer	0.000613	0.00776	CcSEcCtD
Aminosalicylic Acid—PTGS2—liver—colon cancer	0.000612	0.00434	CbGeAlD
Aminosalicylic Acid—Anaemia—Irinotecan—colon cancer	0.000597	0.00755	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Vincristine—colon cancer	0.000593	0.00751	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Irinotecan—colon cancer	0.000578	0.00731	CcSEcCtD
Aminosalicylic Acid—Anaemia—Fluorouracil—colon cancer	0.000572	0.00723	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—colon cancer	0.000566	0.00716	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Capecitabine—colon cancer	0.000561	0.0071	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Fluorouracil—colon cancer	0.000554	0.00701	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Capecitabine—colon cancer	0.000542	0.00686	CcSEcCtD
Aminosalicylic Acid—Jaundice—Capecitabine—colon cancer	0.000539	0.00682	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Vincristine—colon cancer	0.000531	0.00672	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vincristine—colon cancer	0.00053	0.0067	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ABCB1—colon cancer	0.000528	0.101	CrCbGaD
Aminosalicylic Acid—Nervous system disorder—Irinotecan—colon cancer	0.000517	0.00654	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Capecitabine—colon cancer	0.000516	0.00653	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Irinotecan—colon cancer	0.000516	0.00653	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vincristine—colon cancer	0.000516	0.00653	CcSEcCtD
Aminosalicylic Acid—Anorexia—Irinotecan—colon cancer	0.000502	0.00636	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Capecitabine—colon cancer	0.000496	0.00628	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Fluorouracil—colon cancer	0.000495	0.00626	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Fluorouracil—colon cancer	0.000494	0.00625	CcSEcCtD
Aminosalicylic Acid—PTGS1—lymph node—colon cancer	0.000491	0.00348	CbGeAlD
Aminosalicylic Acid—Urinary tract disorder—Capecitabine—colon cancer	0.00049	0.0062	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Capecitabine—colon cancer	0.000487	0.00616	CcSEcCtD
Aminosalicylic Acid—Anorexia—Fluorouracil—colon cancer	0.000481	0.00609	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vincristine—colon cancer	0.00047	0.00595	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymph node—colon cancer	0.00047	0.00333	CbGeAlD
Aminosalicylic Acid—Gastrointestinal disorder—Vincristine—colon cancer	0.000467	0.00591	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Irinotecan—colon cancer	0.000458	0.0058	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Irinotecan—colon cancer	0.000455	0.00576	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vincristine—colon cancer	0.000442	0.0056	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Fluorouracil—colon cancer	0.000439	0.00555	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000436	0.00551	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Capecitabine—colon cancer	0.000432	0.00547	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Irinotecan—colon cancer	0.000431	0.00545	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vincristine—colon cancer	0.000428	0.00541	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vincristine—colon cancer	0.000428	0.00541	CcSEcCtD
Aminosalicylic Acid—Flatulence—Capecitabine—colon cancer	0.000426	0.00539	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Capecitabine—colon cancer	0.000423	0.00536	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Irinotecan—colon cancer	0.000417	0.00527	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Irinotecan—colon cancer	0.000417	0.00527	CcSEcCtD
Aminosalicylic Acid—Urticaria—Fluorouracil—colon cancer	0.000401	0.00507	CcSEcCtD
Aminosalicylic Acid—Anaemia—Capecitabine—colon cancer	0.000399	0.00505	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Fluorouracil—colon cancer	0.000399	0.00505	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vincristine—colon cancer	0.000399	0.00505	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Irinotecan—colon cancer	0.000388	0.00491	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Capecitabine—colon cancer	0.000387	0.0049	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—colon cancer	0.000384	0.00486	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Fluorouracil—colon cancer	0.000372	0.00471	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vincristine—colon cancer	0.00037	0.00469	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—colon cancer	0.00037	0.00468	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000365	0.00462	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—colon cancer	0.000365	0.00462	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—colon cancer	0.000362	0.00458	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Irinotecan—colon cancer	0.000361	0.00456	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vincristine—colon cancer	0.000358	0.00453	CcSEcCtD
Aminosalicylic Acid—Dizziness—Irinotecan—colon cancer	0.000348	0.00441	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Capecitabine—colon cancer	0.000346	0.00438	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fluorouracil—colon cancer	0.000345	0.00437	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Capecitabine—colon cancer	0.000345	0.00437	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vincristine—colon cancer	0.000344	0.00435	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Capecitabine—colon cancer	0.000343	0.00434	CcSEcCtD
Aminosalicylic Acid—Rash—Vincristine—colon cancer	0.000341	0.00432	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vincristine—colon cancer	0.000341	0.00431	CcSEcCtD
Aminosalicylic Acid—Headache—Vincristine—colon cancer	0.000339	0.00429	CcSEcCtD
Aminosalicylic Acid—Anorexia—Capecitabine—colon cancer	0.000336	0.00425	CcSEcCtD
Aminosalicylic Acid—Vomiting—Irinotecan—colon cancer	0.000335	0.00424	CcSEcCtD
Aminosalicylic Acid—Dizziness—Fluorouracil—colon cancer	0.000334	0.00422	CcSEcCtD
Aminosalicylic Acid—Rash—Irinotecan—colon cancer	0.000332	0.00421	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Irinotecan—colon cancer	0.000332	0.0042	CcSEcCtD
Aminosalicylic Acid—Headache—Irinotecan—colon cancer	0.00033	0.00418	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—colon cancer	0.000322	0.00407	CcSEcCtD
Aminosalicylic Acid—Nausea—Vincristine—colon cancer	0.000321	0.00407	CcSEcCtD
Aminosalicylic Acid—Vomiting—Fluorouracil—colon cancer	0.000321	0.00406	CcSEcCtD
Aminosalicylic Acid—Rash—Fluorouracil—colon cancer	0.000318	0.00403	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Fluorouracil—colon cancer	0.000318	0.00402	CcSEcCtD
Aminosalicylic Acid—Headache—Fluorouracil—colon cancer	0.000316	0.004	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—colon cancer	0.000315	0.00399	CcSEcCtD
Aminosalicylic Acid—Nausea—Irinotecan—colon cancer	0.000313	0.00396	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Capecitabine—colon cancer	0.000307	0.00388	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Capecitabine—colon cancer	0.000304	0.00385	CcSEcCtD
Aminosalicylic Acid—Nausea—Fluorouracil—colon cancer	0.0003	0.00379	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—colon cancer	0.000297	0.00376	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Capecitabine—colon cancer	0.000288	0.00365	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—colon cancer	0.000288	0.00364	CcSEcCtD
Aminosalicylic Acid—Urticaria—Capecitabine—colon cancer	0.00028	0.00355	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Capecitabine—colon cancer	0.000279	0.00353	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Capecitabine—colon cancer	0.000279	0.00353	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000272	0.00344	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Capecitabine—colon cancer	0.00026	0.00329	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—colon cancer	0.000257	0.00326	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—colon cancer	0.000257	0.00325	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—colon cancer	0.000255	0.00323	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—colon cancer	0.00025	0.00317	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Capecitabine—colon cancer	0.000241	0.00305	CcSEcCtD
Aminosalicylic Acid—Dizziness—Capecitabine—colon cancer	0.000233	0.00295	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—colon cancer	0.000228	0.00289	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—colon cancer	0.000227	0.00287	CcSEcCtD
Aminosalicylic Acid—Vomiting—Capecitabine—colon cancer	0.000224	0.00284	CcSEcCtD
Aminosalicylic Acid—Rash—Capecitabine—colon cancer	0.000222	0.00281	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Capecitabine—colon cancer	0.000222	0.00281	CcSEcCtD
Aminosalicylic Acid—Headache—Capecitabine—colon cancer	0.000221	0.0028	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—colon cancer	0.000215	0.00272	CcSEcCtD
Aminosalicylic Acid—Nausea—Capecitabine—colon cancer	0.000209	0.00265	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—colon cancer	0.000209	0.00264	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—colon cancer	0.000208	0.00263	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—colon cancer	0.000208	0.00263	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—colon cancer	0.000193	0.00245	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—colon cancer	0.00018	0.00227	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—colon cancer	0.000174	0.0022	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—colon cancer	0.000167	0.00211	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—colon cancer	0.000166	0.0021	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—colon cancer	0.000165	0.00209	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—colon cancer	0.000164	0.00208	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—colon cancer	0.000156	0.00197	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—colon cancer	0.000119	0.000931	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—KRAS—colon cancer	0.000119	0.00093	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—colon cancer	0.000119	0.000927	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—PIK3CA—colon cancer	0.000117	0.000918	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—colon cancer	0.000117	0.000913	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000117	0.000912	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CCND1—colon cancer	0.000117	0.000911	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—PIK3CA—colon cancer	0.000116	0.000908	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000116	0.000903	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AXIN2—colon cancer	0.000114	0.000894	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL10—colon cancer	0.000114	0.000891	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—KRAS—colon cancer	0.000114	0.000888	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	0.000113	0.000886	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NRAS—colon cancer	0.000113	0.000886	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—KRAS—colon cancer	0.000113	0.000884	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ODC1—colon cancer	0.000113	0.000881	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CHST5—colon cancer	0.000113	0.000881	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—SRC—colon cancer	0.000113	0.000881	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—KRAS—colon cancer	0.000113	0.00088	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—KRAS—colon cancer	0.000112	0.000875	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—colon cancer	0.000112	0.000872	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—colon cancer	0.000112	0.000872	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—colon cancer	0.000112	0.000872	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—PIK3CA—colon cancer	0.000111	0.000868	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—colon cancer	0.000111	0.000864	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—colon cancer	0.00011	0.000863	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—colon cancer	0.00011	0.000856	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—PIK3CA—colon cancer	0.000109	0.000855	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—colon cancer	0.000109	0.000853	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—colon cancer	0.000108	0.000848	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—colon cancer	0.000107	0.00084	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000107	0.000839	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000107	0.000837	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000106	0.000832	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000106	0.000831	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—colon cancer	0.000106	0.000826	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—colon cancer	0.000105	0.000824	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—KRAS—colon cancer	0.000105	0.000824	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KRAS—colon cancer	0.000105	0.000824	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000105	0.00082	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—PIK3CA—colon cancer	0.000104	0.000816	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KRAS—colon cancer	0.000104	0.000816	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—PIK3CA—colon cancer	0.000104	0.000812	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KRAS—colon cancer	0.000104	0.000809	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—PIK3CA—colon cancer	0.000103	0.000808	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—colon cancer	0.000103	0.000807	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KRAS—colon cancer	0.000103	0.000805	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—colon cancer	0.000103	0.000805	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—PIK3CA—colon cancer	0.000103	0.000804	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—colon cancer	0.000103	0.000803	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—colon cancer	0.000101	0.000793	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—colon cancer	0.000101	0.000791	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—EP300—colon cancer	0.000101	0.000786	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CASP3—colon cancer	9.95e-05	0.000778	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	9.92e-05	0.000775	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	9.88e-05	0.000772	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—KRAS—colon cancer	9.75e-05	0.000762	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—PIK3CA—colon cancer	9.68e-05	0.000757	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—PIK3CA—colon cancer	9.68e-05	0.000757	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—PIK3CA—colon cancer	9.68e-05	0.000757	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AXIN2—colon cancer	9.68e-05	0.000756	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—colon cancer	9.66e-05	0.000755	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	9.63e-05	0.000753	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—colon cancer	9.62e-05	0.000751	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	9.6e-05	0.00075	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—PIK3CA—colon cancer	9.6e-05	0.00075	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—colon cancer	9.57e-05	0.000748	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—colon cancer	9.52e-05	0.000744	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—PIK3CA—colon cancer	9.51e-05	0.000743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—colon cancer	9.49e-05	0.000741	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—PIK3CA—colon cancer	9.47e-05	0.00074	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—colon cancer	9.39e-05	0.000733	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1A—colon cancer	9.37e-05	0.000732	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—colon cancer	9.35e-05	0.00073	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	9.34e-05	0.000729	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—colon cancer	9.33e-05	0.000729	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	9.32e-05	0.000729	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2L1—colon cancer	9.18e-05	0.000717	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—colon cancer	9.14e-05	0.000714	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.11e-05	0.000712	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—colon cancer	9.08e-05	0.000709	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—colon cancer	8.98e-05	0.000702	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—PIK3CA—colon cancer	8.96e-05	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—colon cancer	8.96e-05	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—colon cancer	8.96e-05	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—colon cancer	8.96e-05	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—colon cancer	8.94e-05	0.000698	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—colon cancer	8.88e-05	0.000694	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.85e-05	0.000692	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	8.81e-05	0.000689	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—colon cancer	8.8e-05	0.000688	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGFR3—colon cancer	8.77e-05	0.000686	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—colon cancer	8.76e-05	0.000685	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—SRC—colon cancer	8.67e-05	0.000678	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ABCB1—colon cancer	8.66e-05	0.000677	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	8.58e-05	0.00067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—colon cancer	8.53e-05	0.000667	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TYMS—colon cancer	8.51e-05	0.000665	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—colon cancer	8.49e-05	0.000664	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NRAS—colon cancer	8.49e-05	0.000663	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—colon cancer	8.45e-05	0.00066	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGFR3—colon cancer	8.42e-05	0.000658	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—colon cancer	8.41e-05	0.000657	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NRAS—colon cancer	8.34e-05	0.000652	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—colon cancer	8.29e-05	0.000648	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	8.29e-05	0.000648	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	8.14e-05	0.000636	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	7.94e-05	0.00062	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.93e-05	0.000619	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—colon cancer	7.91e-05	0.000618	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	7.91e-05	0.000618	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—colon cancer	7.91e-05	0.000618	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	7.85e-05	0.000613	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—colon cancer	7.84e-05	0.000613	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—colon cancer	7.77e-05	0.000607	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—colon cancer	7.74e-05	0.000605	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—colon cancer	7.68e-05	0.0006	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	7.67e-05	0.000599	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—colon cancer	7.6e-05	0.000594	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.44e-05	0.000582	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PIK3CA—colon cancer	7.44e-05	0.000581	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—colon cancer	7.32e-05	0.000572	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—KRAS—colon cancer	7.3e-05	0.000571	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	7.3e-05	0.00057	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KRAS—colon cancer	7.18e-05	0.000561	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDH1—colon cancer	7.12e-05	0.000556	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	7.1e-05	0.000554	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	7.01e-05	0.000548	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.91e-05	0.00054	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—PIK3CA—colon cancer	6.71e-05	0.000524	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PIK3CA—colon cancer	6.6e-05	0.000515	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.55e-05	0.000512	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	6.36e-05	0.000497	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	6.34e-05	0.000496	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—colon cancer	6.25e-05	0.000488	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	6.22e-05	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—colon cancer	6.21e-05	0.000485	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—colon cancer	6.1e-05	0.000477	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—colon cancer	6.08e-05	0.000475	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—colon cancer	6.02e-05	0.000471	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.87e-05	0.000459	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.87e-05	0.000458	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—colon cancer	5.47e-05	0.000428	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5.4e-05	0.000422	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—colon cancer	5.39e-05	0.000421	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1A—colon cancer	5.35e-05	0.000418	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2L1—colon cancer	5.35e-05	0.000418	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	5.22e-05	0.000408	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1A—colon cancer	5.13e-05	0.000401	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR3—colon cancer	5.11e-05	0.000399	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EP300—colon cancer	5.09e-05	0.000397	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—SRC—colon cancer	4.95e-05	0.000386	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—colon cancer	4.76e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—SRC—colon cancer	4.75e-05	0.000371	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—colon cancer	4.74e-05	0.00037	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR3—colon cancer	4.72e-05	0.000369	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.66e-05	0.000364	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.61e-05	0.000361	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—colon cancer	4.57e-05	0.000357	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.41e-05	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—colon cancer	4.34e-05	0.000339	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APC—colon cancer	4.33e-05	0.000338	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDH1—colon cancer	4.32e-05	0.000337	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—colon cancer	4.16e-05	0.000325	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—colon cancer	4.1e-05	0.00032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BRAF—colon cancer	4.07e-05	0.000318	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—EP300—colon cancer	3.94e-05	0.000308	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—colon cancer	3.93e-05	0.000307	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.84e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—colon cancer	3.76e-05	0.000294	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—colon cancer	3.76e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TYMS—colon cancer	3.69e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—colon cancer	3.61e-05	0.000282	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—colon cancer	3.48e-05	0.000272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—colon cancer	3.34e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR3—colon cancer	3.3e-05	0.000258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—colon cancer	3.29e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—colon cancer	3.19e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1A—colon cancer	3.11e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—colon cancer	3.07e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.05e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APC—colon cancer	3.03e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—colon cancer	2.98e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EP300—colon cancer	2.96e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—colon cancer	2.95e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—colon cancer	2.94e-05	0.00023	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TYMS—colon cancer	2.93e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—colon cancer	2.92e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SRC—colon cancer	2.88e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1A—colon cancer	2.87e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BRAF—colon cancer	2.85e-05	0.000223	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.84e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR3—colon cancer	2.79e-05	0.000218	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—colon cancer	2.77e-05	0.000217	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EP300—colon cancer	2.74e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SRC—colon cancer	2.66e-05	0.000208	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—colon cancer	2.61e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APC—colon cancer	2.57e-05	0.0002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—colon cancer	2.56e-05	0.0002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—colon cancer	2.53e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BRAF—colon cancer	2.41e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—colon cancer	2.39e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—colon cancer	2.38e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—colon cancer	2.38e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—colon cancer	2.38e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—colon cancer	2.33e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.25e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—colon cancer	2.2e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—colon cancer	2.19e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—colon cancer	2.14e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—colon cancer	2.08e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—colon cancer	2.07e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—colon cancer	2.06e-05	0.000161	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—colon cancer	2.06e-05	0.000161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—colon cancer	2.03e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—colon cancer	2.02e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1A—colon cancer	2.01e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EP300—colon cancer	1.92e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—colon cancer	1.87e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SRC—colon cancer	1.86e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—colon cancer	1.81e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—colon cancer	1.79e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—colon cancer	1.79e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—colon cancer	1.74e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—EP300—colon cancer	1.71e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1A—colon cancer	1.7e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—colon cancer	1.67e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—colon cancer	1.67e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—colon cancer	1.65e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—colon cancer	1.63e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EP300—colon cancer	1.62e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SRC—colon cancer	1.58e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—colon cancer	1.54e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—colon cancer	1.52e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—colon cancer	1.42e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—colon cancer	1.41e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—colon cancer	1.41e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—colon cancer	1.38e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—colon cancer	1.37e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—EP300—colon cancer	1.36e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—colon cancer	1.31e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—colon cancer	1.3e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—colon cancer	1.26e-05	9.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—colon cancer	1.2e-05	9.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—colon cancer	1.16e-05	9.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—colon cancer	1.11e-05	8.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—colon cancer	1.03e-05	8.07e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—colon cancer	1e-05	7.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—colon cancer	9.79e-06	7.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—colon cancer	8.2e-06	6.41e-05	CbGpPWpGaD
